Effect of metformin combined with radiotherapy on radiosensitivity of CD44+CD24- MCF-7 cells in breast cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023063

Enrollment

Unknown

Registered

2019-05-09

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

1:use metformin

2:radiotherapy

3:metformin and radiotherapy

4:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: breast cancer cell MCF-7 whth CD44+CD24-

Exclusion criteria

Exclusion criteria: no exclusion criteria.

Design outcomes

Primary

Measure	Time frame
MCF-7 cancer cell with CD44+CD24-;	—

Countries

China

Contacts

Public ContactLuo Daiqin

Affiliated Hospital of Guizhou Medical University

luodaiqin@aliyun.com+86 15285199963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026